{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:29:36Z","timestamp":1789684176287,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54GM115516"],"award-info":[{"award-number":["U54GM115516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P20GM121301"],"award-info":[{"award-number":["P20GM121301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R50CA265331"],"award-info":[{"award-number":["R50CA265331"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R37CA245330"],"award-info":[{"award-number":["R37CA245330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-19-037-01-LIB"],"award-info":[{"award-number":["RSG-19-037-01-LIB"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jbo.2024.100609","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T21:09:49Z","timestamp":1716325789000},"page":"100609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Adipocytes and metabolism: Contributions to multiple myeloma"],"prefix":"10.1016","volume":"46","author":[{"given":"Heather","family":"Fairfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Schimelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela R.","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2024.100609_b0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","author":"Croucher","year":"2016","journal-title":"Nature reviews. Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2024.100609_b0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00774-023-01403-4","article-title":"Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents","volume":"41","author":"Teramachi","year":"2023","journal-title":"J. Bone Miner. Metab."},{"issue":"10","key":"10.1016\/j.jbo.2024.100609_b0015","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1111\/cas.15087","article-title":"Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma","volume":"112","author":"Ikeda","year":"2021","journal-title":"Cancer Sci."},{"issue":"15","key":"10.1016\/j.jbo.2024.100609_b0020","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/cancers14153796","article-title":"A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments","volume":"14","author":"Herv\u00e1s-Salcedo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jbo.2024.100609_b0025","doi-asserted-by":"crossref","unstructured":"Marques-Mourlet, C., et al., Obesity and myeloma: Clinical and mechanistic contributions to disease progression, in Frontiers in endocrinology. 2023, Front Endocrinol (Lausanne). p. 1118691.","DOI":"10.3389\/fendo.2023.1118691"},{"key":"10.1016\/j.jbo.2024.100609_b0030","doi-asserted-by":"crossref","unstructured":"Wang, Z., et al., Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance, in Journal of Experimental and Clinical Cancer Research. 2022, BioMed Central Ltd. p. 1-18.","DOI":"10.1186\/s13046-021-02209-w"},{"key":"10.1016\/j.jbo.2024.100609_b0035","doi-asserted-by":"crossref","unstructured":"Panaroni, C., et al., Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins, in Blood. 2022, Blood. p. 876-888.","DOI":"10.1182\/blood.2021013832"},{"issue":"14","key":"10.1016\/j.jbo.2024.100609_b0040","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1182\/bloodadvances.2022008345","article-title":"The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma","volume":"7","author":"Findlay","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.jbo.2024.100609_b0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","article-title":"Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbo.2024.100609_b0050","doi-asserted-by":"crossref","unstructured":"Shah, U.A., et al., Extreme body mass index and survival in newly diagnosed multiple myeloma patients, in Blood Cancer Journal. 2023, Nature Publishing Group.","DOI":"10.1038\/s41408-022-00782-7"},{"key":"10.1016\/j.jbo.2024.100609_b0055","series-title":"Leukemia","first-page":"301","article-title":"A comprehensive review of the impact of obesity on plasma cell disorders","author":"Parikh","year":"2022"},{"issue":"7","key":"10.1016\/j.jbo.2024.100609_b0060","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/bloodadvances.2023010843","article-title":"Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population","volume":"8","author":"Lee","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbo.2024.100609_b0065","doi-asserted-by":"crossref","first-page":"e51368","DOI":"10.2196\/51368","article-title":"Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial","volume":"13","author":"Lee","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.jbo.2024.100609_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-024-07059-x","article-title":"Correlation Between Bariatric Surgery and the Risk of Multiple Myeloma: Results from an Evidence-Based Strategy","author":"Wu","year":"2024","journal-title":"Obes. Surg."},{"key":"10.1016\/j.jbo.2024.100609_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2024.01.002","article-title":"An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma","author":"Alodhaibi","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.jbo.2024.100609_b0080","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood-2021-151878","article-title":"A Randomized Placebo-Controlled Phase 2 Study of Metformin for the Prevention of Progression of Monoclonal Gammopathy of Undetermined Significance and Low Risk Smoldering Multiple Myeloma","volume":"138","author":"Marinac","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jbo.2024.100609_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/path.6066","article-title":"Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis","volume":"260","author":"Van der Vreken","year":"2023","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.jbo.2024.100609_b0090","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1038\/s41598-024-54193-8","article-title":"Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma","volume":"14","author":"Nedal","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbo.2024.100609_b0095","doi-asserted-by":"crossref","unstructured":"Ambrosi, T.H., et al., Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration, in Cell Stem Cell. 2017. p. 771-784.e6.","DOI":"10.1016\/j.stem.2017.02.009"},{"key":"10.1016\/j.jbo.2024.100609_b0100","doi-asserted-by":"crossref","unstructured":"Carmona, R., et al., Fat composition changes in bone marrow during chemotherapy and radiation therapy., in International journal of radiation oncology, biology, physics. 2014. p. 155-63.","DOI":"10.1016\/j.ijrobp.2014.05.041"},{"issue":"1","key":"10.1016\/j.jbo.2024.100609_b0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18632\/oncotarget.28548","article-title":"Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma","volume":"15","author":"El-Masri","year":"2024","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jbo.2024.100609_b0110","doi-asserted-by":"crossref","first-page":"e195313","DOI":"10.1001\/jamanetworkopen.2019.5313","article-title":"Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis","volume":"2","author":"Catal\u00e1-L\u00f3pez","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jbo.2024.100609_b0115","doi-asserted-by":"crossref","unstructured":"Li, Z. and C.J. Rosen, The Multifaceted Roles of Bone Marrow Adipocytes in Bone and Hematopoietic Homeostasis, in The Journal of clinical endocrinology and metabolism. 2023, J Clin Endocrinol Metab.","DOI":"10.1210\/clinem\/dgad355"},{"key":"10.1016\/j.jbo.2024.100609_b0120","doi-asserted-by":"crossref","unstructured":"Liu, H., et al., Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease., in Science translational medicine. 2019. p. eaau9087.","DOI":"10.1126\/scitranslmed.aau9087"},{"issue":"5","key":"10.1016\/j.jbo.2024.100609_b0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jbmr.3951","article-title":"Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha","volume":"35","author":"Morris","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.jbo.2024.100609_b0130","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-20-1088","article-title":"Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype","volume":"81","author":"Fairfield","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2024.100609_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897862","article-title":"Multiple myeloma metabolism - a treasure trove of therapeutic targets?","volume":"13","author":"Roman-Trufero","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbo.2024.100609_b0140","doi-asserted-by":"crossref","unstructured":"Murphy, C.S., et al., Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial Dysfunction. bioRxiv, 2024: p. 2024.03.13.583708.","DOI":"10.1101\/2024.03.13.583708"},{"issue":"3","key":"10.1016\/j.jbo.2024.100609_b0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/carcin\/bgad015","article-title":"ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis","volume":"44","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.jbo.2024.100609_b0150","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/bloodadvances.2022007383","article-title":"AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity","volume":"7","author":"Bloedjes","year":"2023","journal-title":"Blood Adv."},{"issue":"23","key":"10.1016\/j.jbo.2024.100609_b0155","first-page":"2841","article-title":"CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma","volume":"141","author":"Yao","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jbo.2024.100609_b0160","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.1111\/cpr.13388","article-title":"Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma","volume":"56","author":"Barbato","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jbo.2024.100609_b0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-015-0008-z","article-title":"Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1","volume":"4","author":"Fujiwara","year":"2015","journal-title":"Exp. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2024.100609_b0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10787-022-00980-6","article-title":"The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jbo.2024.100609_b0175","doi-asserted-by":"crossref","unstructured":"Farrell, M., et al., Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling, in eLife. 2023, Elife.","DOI":"10.7554\/eLife.81184.sa2"},{"key":"10.1016\/j.jbo.2024.100609_b0180","doi-asserted-by":"crossref","unstructured":"Jia, H., et al., FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma, in Frontiers in Medicine. 2021, Frontiers Media S.A. p. 667525.","DOI":"10.3389\/fmed.2021.667525"},{"key":"10.1016\/j.jbo.2024.100609_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.973836","article-title":"Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche","volume":"12","author":"Solimando","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:30:31Z","timestamp":1769416231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137424000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":37,"alternative-id":["S2212137424000897"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100609","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipocytes and metabolism: Contributions to multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100609"}}